Active Shortage

DOXORUBICIN INJECTION, BP

ACCORD HEALTHCARE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DOXORUBICIN INJECTION, BP in Canada?

Yes. DOXORUBICIN INJECTION, BP 2MG has an active shortage reported to Health Canada (last updated May 30, 2025).

Why is DOXORUBICIN INJECTION, BP not available?

The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.

When will DOXORUBICIN INJECTION, BP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file2 products · 0 same form & route

Affected strength2MG

Report last updated2025-05-30

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CAELYX

BAXTER CORPORATION

2MG · DIN 02238389

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TARO-DOXORUBICIN LIPOSOMAL

TARO PHARMACEUTICALS INC

2MG · DIN 02493020

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02381982

Strength

2MG

Dosage Form

SOLUTION

Route

INTRAVESICAL INTRAVENOUS

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

See all DOXORUBICIN HYDROCHLORIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2025-05-30

Active Shortage

Requirements related to complying with good manufacturing practices.

Other Products from ACCORD HEALTHCARE INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

5MG · DIN 02381478

70MG · DIN 02381494

10MG · DIN 02381486

10MG · DIN 02419572

2.5MG · DIN 02419556

5MG · DIN 02419564